{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:53:49Z","timestamp":1784328829788,"version":"3.55.0"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Cardiomyopathies are complex heart diseases with significant prevalence around the world. Among these, primary forms are the major contributors to heart failure and sudden cardiac death. As a high-energy demanding engine, the heart utilizes fatty acids, glucose, amino acid, lactate and ketone bodies for energy to meet its requirement. However, continuous myocardial stress and cardiomyopathies drive towards metabolic impairment that advances heart failure (HF) pathogenesis. So far, metabolic profile correlation across different cardiomyopathies remains poorly understood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, we systematically explore metabolic differences amongst primary cardiomyopathies. By assessing the metabolic gene expression of all primary cardiomyopathies, we highlight the significantly shared and distinct metabolic pathways that may represent specialized adaptations to unique cellular demands. We utilized publicly available RNA-seq datasets to profile global changes in the above diseases (|<jats:italic>log2FC<\/jats:italic>| \u2265 0.28 and BH\u00a0<jats:italic>adjusted p-val<\/jats:italic> 0.1) and performed gene set analysis (GSA) using the PAGE statistics on KEGG pathways.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our analysis demonstrates that genes in arachidonic acid metabolism (AA) are significantly perturbed across cardiomyopathies. In particular, the arachidonic acid metabolism gene <jats:italic>PLA2G2A<\/jats:italic> interacts with fibroblast marker genes and can potentially influence fibrosis during cardiomyopathy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The profound significance of AA metabolism within the cardiovascular system renders it a key player in modulating the phenotypes of cardiomyopathies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2023.1110119","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T04:32:41Z","timestamp":1684816361000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Transcriptome data analysis of primary cardiomyopathies reveals perturbations in arachidonic acid metabolism"],"prefix":"10.3389","volume":"10","author":[{"given":"Pankaj Kumar","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramanathan","family":"Sowdhamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","article-title":"Contemporary definitions and classification of the cardiomyopathies","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1172\/JCI17612","article-title":"Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies","volume":"111","author":"Chien","year":"2003","journal-title":"J Clin Invest"},{"key":"B3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/NRCARDIO.2013.105","article-title":"Dilated cardiomyopathy: the complexity of a diverse genetic architecture","volume":"10","author":"Hershberger","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/S0140-6736(09)60256-7","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"373","author":"Basso","year":"2009","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41569-020-0428-2","article-title":"Epidemiology of the inherited cardiomyopathies","volume":"18","author":"McKenna","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/CVR\/CVV024","article-title":"Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations","volume":"105","author":"Olivotto","year":"2015","journal-title":"Cardiovasc Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41569-022-00682-0","article-title":"Targeting the sarcomere in inherited cardiomyopathies","volume":"19","author":"Lehman","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1161\/CIRCRESAHA.117.306458","article-title":"Environmental determinants of cardiovascular disease","volume":"121","author":"Bhatnagar","year":"2017","journal-title":"Circ Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"H2050","DOI":"10.1152\/AJPHEART.00120.2011","article-title":"Chronic oral exposure to the aldehyde pollutant acrolein induces dilated cardiomyopathy","volume":"301","author":"Ismahil","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1001\/JAMA.2009.1062","article-title":"Relation between modifiable lifestyle factors and lifetime risk of heart failure: the Physicians\u2019 health study I","volume":"302","author":"Djouss\u00e9","year":"2009","journal-title":"J Am Med Assoc"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1378\/CHEST.121.5.1638","article-title":"Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology","volume":"121","author":"Piano","year":"2002","journal-title":"Chest"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJMRA063052","article-title":"The failing heart: an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1161\/01.CIR.0000139340.88769.D5","article-title":"Cardiac metabolism as a target for the treatment of heart failure","volume":"110","author":"Taegtmeyer","year":"2004","journal-title":"Circulation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.3390\/IJMS22041999","article-title":"Energy metabolites as biomarkers in ischemic and dilated cardiomyopathy","volume":"22","author":"Haas","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/METABO11040195\/S1","article-title":"Metabolic signature of arrhythmogenic cardiomyopathy","volume":"11","author":"Volani","year":"2021","journal-title":"Metabolites"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.3390\/JCM8122195","article-title":"Metabolic alterations in inherited cardiomyopathies","volume":"8","author":"Sacchetto","year":"2019","journal-title":"J Clin Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/J.IJCARD.2016.06.022","article-title":"Metabolomics\u2014a wide-open door to personalized treatment in chronic heart failure?","volume":"219","author":"Marcinkiewicz-Siemion","year":"2016","journal-title":"Int J Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1093\/IJE\/DYW271","article-title":"Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future","volume":"45","author":"Rankin","year":"2016","journal-title":"Int J Epidemiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0134184","DOI":"10.1371\/JOURNAL.PONE.0134184","article-title":"The metabolome in Finnish carriers of the MYBPC3-Q1061X mutation for hypertrophic cardiomyopathy","volume":"10","author":"J\u00f8rgenrud","year":"2015","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/J.1365-2362.2010.02441.X","article-title":"Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy","volume":"41","author":"Alexander","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1093\/CVR\/CVY147","article-title":"Metabolic changes in hypertrophic cardiomyopathies: scientific update from the working group of myocardial function of the European society of cardiology","volume":"114","author":"van der Velden","year":"2018","journal-title":"Cardiovasc Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13148-021-01043-3\/FIGURES\/6","article-title":"Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations","volume":"13","author":"Pei","year":"2021","journal-title":"Clin Epigenetics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12864-018-5213-9\/FIGURES\/7","article-title":"Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure","volume":"19","author":"Sweet","year":"2018","journal-title":"BMC Genomics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-11738-0","article-title":"Metabolic landscape of the tumor microenvironment at single cell resolution","volume":"10","author":"Xiao","year":"2019","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms13041","article-title":"Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival","volume":"7","author":"Gaude","year":"2016","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-022-03135-z","article-title":"Identifying metabolic reprogramming phenotypes with glycolysis-lipid metabolism discoordination and intercellular communication for lung adenocarcinoma metastasis","volume":"5","author":"Li","year":"2022","journal-title":"Commun Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e79217","DOI":"10.1371\/JOURNAL.PONE.0079217","article-title":"A comparison of gene set analysis methods in terms of sensitivity, prioritization and specificity","volume":"8","author":"Tarca","year":"2013","journal-title":"PLoS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/J.TIBTECH.2005.05.011","article-title":"Pathways to the analysis of microarray data","volume":"23","author":"Curtis","year":"2005","journal-title":"Trends Biotechnol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep14563","article-title":"Reporter pathway analysis from transcriptome data: metabolite-centric versus reaction-centric approach","volume":"5","author":"\u00c7akir","year":"2015","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B32","doi-asserted-by":"publisher","first-page":"641","DOI":"10.4049\/JIMMUNOL.178.2.641","article-title":"Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation","volume":"178","author":"Levick","year":"2007","journal-title":"J Immun"},{"key":"B33","doi-asserted-by":"publisher","first-page":"12029","DOI":"10.3390\/IJMS222112029","article-title":"Effects of arachidonic acid metabolites on cardiovascular health and disease","volume":"22","author":"Zhou","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1124\/PR.56.3.3","article-title":"Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharmacol Rev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"106620","DOI":"10.1016\/J.PROSTAGLANDINS.2022.106620","article-title":"14,15-EET involved in the development of diabetic cardiac hypertrophy mediated by PPARs","volume":"159","author":"Zhang","year":"2022","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"B36","doi-asserted-by":"publisher","first-page":"19413","DOI":"10.1074\/JBC.M116.741454","article-title":"Membrane-dependent activities of human 15-LOX-2 and its murine counterpart: implications for murine models of atherosclerosis","volume":"291","author":"Bender","year":"2016","journal-title":"J Biol Chem"},{"key":"B37","doi-asserted-by":"publisher","first-page":"113326","DOI":"10.1016\/J.BIOPHA.2022.113326","article-title":"Epoxyeicosatrienoic acid: a potential therapeutic target of heart failure with preserved ejection fraction","volume":"153","author":"Zhang","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1074\/JBC.271.7.3460","article-title":"Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart","volume":"271","author":"Wu","year":"1996","journal-title":"J Biol Chem"},{"key":"B39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/FPHYS.2021.642470\/BIBTEX","article-title":"The role of epoxyeicosatrienoic acids in cardiac remodeling","volume":"12","author":"Lai","year":"2021","journal-title":"Front Physiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1152\/AJPHEART.2001.280.6.H2823\/ASSET\/IMAGES\/LARGE\/H40710863005.JPEG","article-title":"Cytochrome P-450 metabolite of arachidonic acid mediates bradykinin-induced negative inotropic effect","volume":"280","author":"Rastaldo","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nrd2875","article-title":"Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases","volume":"8","author":"Imig","year":"2009","journal-title":"Nat Rev Drug Discovery"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/CIRCRESAHA.121.320548","article-title":"Therapeutic and prognostic significance of arachidonic acid in heart failure","volume":"130","author":"Ma","year":"2022","journal-title":"Circ Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.3390\/IJMS19113285","article-title":"Arachidonic acid metabolites in cardiovascular and metabolic diseases","volume":"19","author":"Sonnweber","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s44161-022-00028-6","article-title":"Single-cell transcriptomics reveals cell-type-specific diversification in human heart failure","volume":"1","author":"Koenig","year":"2022","journal-title":"Nat Cardiol Rev"},{"key":"B45","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13059-014-0550-8\/FIGURES\/9","article-title":"Moderated estimation of fold change and dispersion for RNA-Seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1090\/S0002-9947-1943-0012401-3","article-title":"Tests of statistical hypotheses concerning several parameters when the number of observations is large","volume":"54","author":"Wald","year":"1943","journal-title":"Trans Am Math Soc"},{"key":"B48","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/J.2517-6161.1995.TB02031.X","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/NAR\/GKV007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/J.CELL.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1471-2105-6-144","article-title":"PAGE: parametric analysis of gene set enrichment","volume":"6","author":"Kim","year":"2005","journal-title":"BMC Bioinform"},{"key":"B52","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.1093\/NAR\/GKT111","article-title":"Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods","volume":"41","author":"V\u00e4remo","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"W501","DOI":"10.1093\/NAR\/GKX372","article-title":"Pathview web: user friendly pathway visualization and data integration","volume":"45","author":"Luo","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"W191","DOI":"10.1093\/NAR\/GKZ369","article-title":"g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)","volume":"47","author":"Raudvere","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-24246-x","article-title":"Integrative network analysis interweaves the missing links in cardiomyopathy diseasome","volume":"12","author":"Chauhan","year":"2022","journal-title":"Sci Rep"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-63563-x","article-title":"RNA sequence analyses throughout the course of mouse cardiac laminopathy identify differentially expressed genes for cell cycle control and mitochondrial function","volume":"10","author":"Shao","year":"2020","journal-title":"Sci Rep"},{"key":"B57","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1093\/EURHEARTJ\/EHX808","article-title":"Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias","volume":"39","author":"Verdonschot","year":"2018","journal-title":"Eur Heart J"},{"key":"B58","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1152\/AJPHEART.00906.2009\/ASSET\/IMAGES\/LARGE\/ZH40071094200008.JPEG","article-title":"Role of arachidonic acid, lipoxygenase, and mitochondrial depolarization in reperfusion arrhythmias","volume":"299","author":"Haworth","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"eabf0891","DOI":"10.1126\/SCITRANSLMED.ABF0891\/SUPPL_FILE\/ABF0891_SM.PDF","article-title":"Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathy","volume":"13","author":"Chelko","year":"2021","journal-title":"Sci Transl Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/FCVM.2023.1114459\/BIBTEX","article-title":"Targeting lipid metabolism as a new therapeutic strategy for inherited cardiomyopathies","volume":"10","author":"Gaar-Humphreys","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3389\/FCVM.2021.694238","article-title":"AKR1C3 and its transcription factor HOXB4 are promising diagnostic biomarkers for acute myocardial infarction","volume":"8","author":"Liang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/J.IHJ.2018.11.011","article-title":"Role of cytochrome epoxygenase (CYP2J2) in the pathophysiology of coronary artery disease in south Indian population","volume":"71","author":"Tantray","year":"2019","journal-title":"Indian Heart J"},{"key":"B63","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/ng.129","article-title":"Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease","volume":"40","author":"Monti","year":"2008","journal-title":"Nat Genet"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e41786","DOI":"10.1371\/JOURNAL.PONE.0041786","article-title":"Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease","volume":"7","author":"Nobili","year":"2012","journal-title":"PLoS One"},{"key":"B65","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1161\/HH1601.095598","article-title":"Phospholipase A2 in vascular disease","volume":"89","author":"Hurt-Camejo","year":"2001","journal-title":"Circ Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12944-022-01696-W\/FIGURES\/6","article-title":"Lipid metabolism patterns and relevant clinical and molecular features of coronary artery disease patients: an integrated bioinformatic analysis","volume":"21","author":"Liao","year":"2022","journal-title":"Lipids Health Dis"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1164\/RCCM.201309-1697OC\/SUPPL_FILE\/DISCLOSURES.PDF","article-title":"Functional prostacyclin synthase promoter polymorphisms impact in pulmonary arterial hypertension","volume":"189","author":"Stearman","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"9772","DOI":"10.1073\/PNAS.0503279102\/SUPPL_FILE\/03279FIG6.PDF","article-title":"Soluble epoxide hydrolase is a therapeutic target for acute inflammation","volume":"102","author":"Schmelzer","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B69","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/J.TCM.2019.09.003","article-title":"Current understanding of fibrosis in genetic cardiomyopathies","volume":"30","author":"Eijgenraam","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/J.YJMCC.2013.10.019","article-title":"Myofibroblasts: trust your heart and let fate decide","volume":"70","author":"Davis","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/J.ADDR.2019.05.011","article-title":"Cardiac fibrosis: a short review of causes and therapeutic strategies","volume":"146","author":"Hinderer","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1089\/HUM.2008.204","article-title":"Decorin gene delivery inhibits cardiac fibrosis in spontaneously hypertensive rats by modulation of transforming growth factor-beta\/smad and p38 mitogen-activated protein kinase signaling pathways","volume":"20","author":"Yan","year":"2009","journal-title":"Hum Gene Ther"},{"key":"B73","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/J.1755-5922.2010.00150.X","article-title":"Soluble epoxide hydrolase inhibitors and heart failure","volume":"29","author":"Qiu","year":"2011","journal-title":"Cardiovasc Ther"},{"key":"B74","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000051053","article-title":"Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin","volume":"38","author":"Imig","year":"2001","journal-title":"J Vasc Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/S00424-010-0804-6\/FIGURES\/4","article-title":"Epoxyeicosatrienoic acids and endothelium-dependent responses","volume":"459","author":"Campbell","year":"2010","journal-title":"Pflugers Arch"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1110119\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T04:32:47Z","timestamp":1684816367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1110119\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":75,"alternative-id":["10.3389\/fcvm.2023.1110119"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1110119","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,23]]},"article-number":"1110119"}}